We hypothesize that lifestyle interventions introduced to women with early-diagnosed GDM to avoid weight gain and increased insulin resistance could have prevented significant reductions in FGF-19 levels in the second and third trimesters. The gene discussed is FGF19; the disease is Insulin resistance.